Hospital acquired rota virus infection: the economics of prevention.
Nosocomial rota virus infection results in costs to patients (for example, delayed procedures) and to hospitals (for example, additional bed-days, and ward closures if an epidemic occurs). This paper analyses the economic efficiency of using a preventive measure--a high antibody milk supplement--in a hospital for children. The cost of implementing this program is compared with the benefits of avoiding nosocomial rota virus infection. The results of the study suggest that, taking a range of realistic values for the most significant variables, the use of the supplement would be cost-effective.